Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma

Hiroyuki Kashiwagi, Jonathan E. McDunn, Peter O. Simon, Peter S. Goedegebuure, Suwanna Vangveravong, Katherine Chang, Richard S. Hotchkiss, Robert H. Mach, William G. Hawkins

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds